CLINICAL_TRIALS
trial_result
· 2017-04-11
Clinical Trial Update: A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression [Phase 2]
Summary
A Phase 2 randomized, double-blind, placebo-controlled trial of riluzole for bipolar depression has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-04-11